Growth Stocks vs Value Stocks: Which Is Better In The Stock Market Today?
What’s The Difference Between Growth and Value Investing? Growth and value refer to two categories of stocks and the investing styles built on their differences.…
investors
Genomics’ Future Is Bright (2021 Market Reflections)
I’m all about systems. My passion lies in building rules-based trading systems that beat the pants off the market while keeping risk under control. It’s…
5 Dividend Paying Stocks To Watch This Week
Are These The Best Dividend Stocks To Invest In Ahead Of October 2021? Even with the broader stock market looking to make a comeback following…
Biotech Buys: 2 Top Picks Under $10
As a result of the pandemic, investors have likely become familiar with a number of biotech names over the past year and a half that…
A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
The Cutting-Edge World Of Proteomics – And What Investors Need To Know
There’s a new type of revolutionary science on the horizon: proteomics. But just what is proteomics – and what do healthcare investors need to know…
How To Approach “Extraordinarily Risky” Clinical-Stage Biotech Stocks
“Investing in any kind of stock can be risky. But investing in clinical-stage biotech stocks can be extraordinarily risky,” acknowledge the authors of today’s article.…
Don’t Run Scared From The Recent Sell-Off In Small And Micro-Cap Stocks – Pounce On It!
“Scared money runs and misses out on profits, while smart money is always poised to pounce on temporary disconnects,” declares the author of today’s article…
Profit From The “Urge To Merge” In The Diagnostics Space
On the heels of the news of Roche acquiring GenMark Diagnostics, the author of today’s article shares two more leading diagnostics companies that he believes are prime…
Will Biotech Buck The Historical Trend This March? (And Where Will Biotech Go After 2021?)
Historically, January and February tend to be very strong months for biotech, while March tends to be very weak. But, with COVID-19 continuing to bear…